Satellos Bioscience
€0.29
0
+€0+0% Today
Statistics
Day High
0.29
Day Low
0.29
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
37.01M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
23NovConfirmed
Expected EPS
-0.07
Actual EPS
-0.05
People Also Follow
This list is based on the watchlists of people on Stock Events who follow 0ITA.F. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Satellos Bioscience Inc., a biotechnology company, develops regenerative therapeutics to treat degenerative muscle diseases primarily in Canada and Australia. The company uses its proprietary platform MyoReGenX, an automated microscopy system which recapitulates the muscle stem cell environment ex-vivo. Its lead program focuses on the discovery and development of a small molecule drug for the treatment of Duchenne. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.
Show more...
CEO
Mr. Francis Gleeson B.B.A. M.B.A
Country
CA
ISIN
CA80401L3083
WKN
000A3CSSM